What is GNMLF's gross margin?

Genomma (GNMLF) has a gross margin of 65% and a net margin of 9%.

What is GNMLF's P/E ratio?

GNMLF's P/E ratio is 7.8 with ROE of 14%.

Where can I see GNMLF's full financials?

See Genomma (GNMLF) income statement, cash flow, and balance sheet — quarterly and annual — alongside insider trading activity.

Genomma (GNMLF) Financials — Revenue, Earnings, Cash Flow

Also trades as: LABB.MX (MEX) · $vol 2M

$0.73

+0.04 (+6.51%)

Weekly Expected Move ±6.6%

$1 $1 $1 $1 $1

OTC · Healthcare · Drug Manufacturers - Specialty & Generic · Tech Score Sell · Power 41 · $713.4M mcap · 671M float · 0.0012% daily turnover · Short 68% of daily vol

Overview Chart Smart Money Financials Income Statement Cash Flow Balance Sheet Earnings

Analysis Technicals Weather Peers ESG Institutions Dark Pool Short Interest

📊 Key Metrics

TTM

$17B

Revenue

+18.2% YoY

$2B

Net Income

+58.3% YoY

$802M

Free Cash Flow

-41.7% YoY

64.6%

Gross Margin

19.9%

Op. Margin

8.5%

Net Margin

💰 Income Flow

How revenue becomes profit

💵 Cash Flow

Where cash goes

🏦 Balance Sheet

Assets = Liabilities + Equity

📈 Financial Health

Profitability

ROE14.1%

ROA6.7%

ROIC14.1%

Valuation

P/E7.8

P/B1.1

EV/EBITDA0.0

Leverage

Debt/Equity0.67

Current Ratio1.41

Interest Cov.3.1x

Quality Scores

Piotroski F5/9

Altman Z—

Beneish M11.66